-
Endocyte is a
biopharmaceutical company established in 1996 and
headquartered in West Lafayette, Indiana, a
resident of the
Purdue Research Park. In 2011...
- research.
Retrieved 2008-10-16. "
Endocyte Appoints David M**** to
Newly Created Position of
Chief Commercial Officer".
Endocyte.
Retrieved 2012-07-26. "David...
-
investigational targeted cancer therapeutic currently under development by
Endocyte and
Merck & Co. It is a
small molecule drug
conjugate consisting of a small...
-
clinical development. In 2017, the ABX
patent was also
acquired by
Endocyte and
Endocyte together with the
above two sets of
patents was
acquired by Novartis...
-
announced it
would acquire Endocyte Inc for $2.1 billion ($24 per share)
merging it with a
newly created subsidiary.
Endocyte will
bolster Novartis' offering...
- of the
developers of Pluvicto. He
cofounded the
biotechnology company Endocyte,
which was
later acquired by Novartis, as well as the biopharmaceutical...
- PMID 29706540. SMDC technology.
Archived 2016-03-27 at the
Wayback Machine ENDOCYTE "
Endocyte announces promising preclinical data for
application of SMDC technology...
- (1876– )
Emcure (1983– )
Emergent (1998– ) EMS (1950– ) Endo (1997– )
Endocyte (1996– )
Epitopoietic Research Corporation (2006– )
Eskayef (1990– ) Esperion...
- well as
pushed for the
acquisition of
Advanced Accelerator Applications,
Endocyte, AveXis, and The
Medicines Company. In
February 2018,
three months after...
- Trials". ClinicalTrials.Gov. U.S.
National Institutes of Health. "Merck,
Endocyte in
Development Deal". dddmag.com. 25
April 2012. "Keytruda".
National Cancer...
